date,title,source
Oct-17-18,5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage,InvestorPlace
Oct-17-18,"Report: Exploring Fundamental Drivers Behind Bellicum Pharmaceuticals, Social Reality, Exelixis, Edgewell Personal Care, Cronos Group, and Acacia Communications  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-18-18,"Exelixis to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018",Business Wire
Oct-19-18,Why Merck's Latest Success Means Trouble for Exelixis Inc.,Motley Fool
Oct-22-18,Exelixis Announces Results from the Dose-Escalation Stage of the Phase 1b COSMIC-021 Study of Cabozantinib in Combination with Atezolizumab in Previously Untreated Advanced Renal Cell Carcinoma,Business Wire
Oct-26-18,Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Exelixis,ACCESSWIRE
Oct-30-18,Exelixis (EXEL) to Report Q3 Earnings: What's in Store?,Zacks
Oct-31-18,Today's Research Reports on Trending Tickers: Exelixis and Sage Therapeutics,ACCESSWIRE
Nov-01-18,Exelixis: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Exelixis Announces Third Quarter 2018 Financial Results and Provides Corporate Update,Business Wire
Nov-05-18,Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market,Motley Fool
Nov-05-18,Edited Transcript of EXEL earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Nov-05-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Exelixis,ACCESSWIRE
